Brooklyn ImmunoTherapeutics (BTX) News Today $6.33 -0.11 (-1.71%) As of 03/28/2025 03:58 PM Eastern Add Share Share Headlines Stock AnalysisChartCompetitorsDividendFinancialsSEC FilingsTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Brooklyn ImmunoTherapeutics (NYSE:BTX) Earns Hold Rating from Analysts at StockNews.comStockNews.com began coverage on Brooklyn ImmunoTherapeutics in a report on Sunday. They set a "hold" rating for the company.March 30 at 2:06 AM | marketbeat.comWhy It’s (Almost) Time to Buy This 15.6% YielderMarch 26, 2025 | marketbeat.comStockNews.com Begins Coverage on Brooklyn ImmunoTherapeutics (NYSE:BTX)March 22, 2025 | americanbankingnews.comBrooklyn ImmunoTherapeutics (NYSE:BTX) Coverage Initiated at StockNews.comStockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics in a research report on Saturday. They set a "hold" rating for the company.March 22, 2025 | marketbeat.comBrooklyn ImmunoTherapeutics (NYSE:BTX) Coverage Initiated by Analysts at StockNews.comStockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics in a report on Friday. They set a "hold" rating on the stock.March 14, 2025 | marketbeat.comStockNews.com Initiates Coverage on Brooklyn ImmunoTherapeutics (NYSE:BTX)StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics in a research note on Thursday. They issued a "hold" rating on the stock.March 6, 2025 | marketbeat.comBrooklyn ImmunoTherapeutics Inc (NYSE:BTX) to Issue Dividend of $0.09Brooklyn ImmunoTherapeutics Inc (NYSE:BTX) declared a dividend on Monday, March 3rd. Shareholders of record on Friday, March 14th will be given a dividend of 0.0862 per share on Monday, March 31st. The ex-dividend date of this dividend is Friday, March 14th.March 5, 2025 | marketbeat.comBrooklyn ImmunoTherapeutics (NYSE:BTX) Now Covered by Analysts at StockNews.comStockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics in a report on Wednesday. They issued a "hold" rating for the company.February 26, 2025 | marketbeat.comBrooklyn ImmunoTherapeutics (NYSE:BTX) Research Coverage Started at StockNews.comStockNews.com started coverage on Brooklyn ImmunoTherapeutics in a research report on Tuesday. They set a "hold" rating for the company.October 29, 2024 | marketbeat.comBrooklyn Nets News, Videos, Schedule, Roster, Stats - Yahoo SportsSeptember 15, 2024 | sports.yahoo.com'Brooklyn Nine-Nine' star Andre Braugher dies at 61December 19, 2023 | abcnews.go.comSabrina Carpenter blows off Catholic Church scandal: ‘Jesus was a carpenter’December 2, 2023 | nypost.comBrooklyn BridgeDecember 2, 2023 | travel.usnews.comBrooklyn Bedding Coupon for NovemberNovember 8, 2023 | time.comDozens of vendors still swarm Brooklyn Bridge in free-for-all — selling illegal cocktails, pics with live snake: photosSeptember 28, 2023 | nypost.comBrooklyn Beckham's wife Nicola Peltz 'to be grilled on camera' over bitter wedding spatAugust 29, 2023 | mirror.co.ukBrooklyn Hospital CenterJune 29, 2023 | health.usnews.comPure joy: the best of Brooklyn’s cool natural wine sceneJune 22, 2023 | ft.comBest Moving Companies In Brooklyn, New York June 2023June 8, 2023 | forbes.comBrooklyn Technical High SchoolMay 7, 2023 | usnews.comBrooklyn Preparatory High SchoolMay 6, 2023 | usnews.comBrooklyn Beckham: Latest news, views, gossip, photos and videoMarch 31, 2023 | dailymail.co.ukBillionaire heiress Nicola Peltz and Brooklyn Beckham saving to buy their 'dream house'March 18, 2023 | mirror.co.ukVictoria Beckham 'fears for son Brooklyn and his wife Nicola' amid wedding lawsuitMarch 11, 2023 | mirror.co.ukIn Brooklyn, a Tiny Apartment and a Neighborhood Filled With FamiliesMarch 1, 2023 | nytimes.comBrooklyn’s priciest rental of 2023 has quickly found a tenantMarch 1, 2023 | nypost.comPolice ask for help identifying driver at the scene of shooting, carjacking in Brooklyn ParkFebruary 26, 2023 | cbsnews.comBrooklyn Nets sign head coach Jacque Vaughn to multiyear contract extensionFebruary 23, 2023 | foxnews.comFor Strictly Observant Jews in Brooklyn, the Sabbath ExpandsFebruary 19, 2023 | nytimes.com7 Times Brooklyn Beckham Got Roasted for His Questionable Cooking SkillsFebruary 5, 2023 | yahoo.comCruz Beckham teaches brother Brooklyn how to cook as he whips up a pizza on family outing in MiamiJanuary 30, 2023 | dailymail.co.ukLike Brooklyn Beckham, I’m a ‘one of the girls’ husband — and I love itJanuary 28, 2023 | nypost.comVictoria Beckham ignores Brooklyn and Nicola's anniversary posts as she teases book clubNovember 12, 2022 | mirror.co.ukBrooklyn ImmunoTherapeutics Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Quarterly Report on Form 10-QNovember 4, 2022 | finance.yahoo.comBrooklyn ImmunoTherapeutics Announces Changes to Executive Management: Matt Angel, Ph.D. Appointed Interim Chief Executive Officer and President, Andrew Jackson Appointed Chief Financial Officer Postpones 2022 Annual MeetingNovember 4, 2022 | finance.yahoo.comBrooklyn ImmunoTherapeutics Announces Board ChangesNovember 4, 2022 | finance.yahoo.comBrooklyn ImmunoTherapeutics Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price DeficiencyNovember 4, 2022 | finance.yahoo.comBrooklyn ImmunoTherapeutics Announces Results of Phase 2 Study of IRX-2 in Head and Neck CancerNovember 4, 2022 | finance.yahoo.comBrooklyn ImmunoTherapeutics Shares Tick lower After Data From Head and Neck Cancer StudyNovember 4, 2022 | finance.yahoo.comBrooklyn ImmunoTherapeutics Announces Name Change to Eterna Therapeutics and Provides Corporate UpdatesNovember 4, 2022 | finance.yahoo.comBrooklyn ImmunoTherapeutic changing name to Eterna Therapeutics on MondayNovember 4, 2022 | finance.yahoo.comEterna Therapeutics Completes Name Change, Acquires Option to License iPSC-Derived NK and T Cell Therapies from Exacis BiotherapeuticsNovember 4, 2022 | finance.yahoo.comEterna Therapeutics to Present at iPSC-Derived Immunotherapies CongressNovember 4, 2022 | finance.yahoo.com Remove Ads Get Brooklyn ImmunoTherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BTX and its competitors with MarketBeat's FREE daily newsletter. Email Address BTX Media Mentions By Week BTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BTX News Sentiment▼0.000.98▲Average News Sentiment BTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BTX Articles This Week▼20▲BTX Articles Average Week Remove Ads Get Brooklyn ImmunoTherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BTX) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brooklyn ImmunoTherapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Brooklyn ImmunoTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BTX Stock Free BTX Stock Alerts